[go: up one dir, main page]

CO5611168A2 - Biomateriales novedosos, su preparacion y su uso - Google Patents

Biomateriales novedosos, su preparacion y su uso

Info

Publication number
CO5611168A2
CO5611168A2 CO04107397A CO04107397A CO5611168A2 CO 5611168 A2 CO5611168 A2 CO 5611168A2 CO 04107397 A CO04107397 A CO 04107397A CO 04107397 A CO04107397 A CO 04107397A CO 5611168 A2 CO5611168 A2 CO 5611168A2
Authority
CO
Colombia
Prior art keywords
precipitate
component
components
cyclodextrin
preparation
Prior art date
Application number
CO04107397A
Other languages
English (en)
Inventor
Lajos Szente
Jozsef Szejtli
Gyorgy Lajos Kis
Christian Schoch
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO5611168A2 publication Critical patent/CO5611168A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/80—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special chemical form
    • A61L2300/802—Additives, excipients, e.g. cyclodextrins, fatty acids, surfactants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

1.- Un precipitado que comprende por lo menos un componente polimérico aniónico, el cual es soluble en agua y un componente de tipo amonio anfifílico, dicho precipitado se puede obtener a través de un procedimiento que incluye los siguientes pasos:1. poner en contacto el componente polimérico aniónico y un componente de ciclodextrina en un medio acuoso, y 2. agregar a la mezcla obtenida en el paso 1 dicho componente de tipo amonio anfifílico.en donde los componentes están presentes en cantidades efectivas para formar dicho precipitado.2.- Un precipitado de acuerdo con la reivindicación 1, que comprende además el componente de ciclodextrina.3.- Un precipitado de acuerdo con la reivindicación 1 o 2, que comprende además uno o más de otros componentes distintos al componente de ciclodextrina, que se agrega en el curso del paso 1 y/o 2 de dicho procedimiento.4.- Un precipitado de acuerdo con la reivindicación 3, en donde uno o más de los otros componentes se selecciona de agentes farmacéuticamente activos, pesticidas, agroquímicos, colorantes, diagnósticos, enzimas y productos alimenticios.
CO04107397A 2002-04-19 2004-10-26 Biomateriales novedosos, su preparacion y su uso CO5611168A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02008809 2002-04-19

Publications (1)

Publication Number Publication Date
CO5611168A2 true CO5611168A2 (es) 2006-02-28

Family

ID=29225593

Family Applications (1)

Application Number Title Priority Date Filing Date
CO04107397A CO5611168A2 (es) 2002-04-19 2004-10-26 Biomateriales novedosos, su preparacion y su uso

Country Status (19)

Country Link
US (3) US20050163853A1 (es)
EP (1) EP1499361B1 (es)
JP (1) JP4648632B2 (es)
KR (1) KR101121675B1 (es)
CN (1) CN1646171B (es)
AU (1) AU2003224099B2 (es)
BR (1) BR0309340A (es)
CA (1) CA2484100C (es)
CO (1) CO5611168A2 (es)
ES (1) ES2392964T3 (es)
IL (1) IL164627A (es)
MX (1) MXPA04010325A (es)
NO (1) NO20044979L (es)
NZ (1) NZ535810A (es)
PL (1) PL215579B1 (es)
PT (1) PT1499361E (es)
RU (1) RU2321597C2 (es)
WO (1) WO2003089008A1 (es)
ZA (1) ZA200407794B (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8377952B2 (en) 2003-08-28 2013-02-19 Abbott Laboratories Solid pharmaceutical dosage formulation
US8025899B2 (en) 2003-08-28 2011-09-27 Abbott Laboratories Solid pharmaceutical dosage form
BRPI0506983A (pt) * 2004-01-20 2007-07-03 Allergan Inc composições para terapia localizada dos olhos, compreendendo preferencialmente acetonida de triancinolona e ácido hialurÈnico
WO2006011044A1 (en) * 2004-07-22 2006-02-02 Pfizer Products Inc. Amorphous cyclodextrin compositions
US8246949B2 (en) * 2004-10-27 2012-08-21 Aciont, Inc. Methods and devices for sustained in-vivo release of an active agent
EP1787658B1 (en) 2005-11-10 2012-03-14 CHEMI S.p.A. Sustained release formulations of somatostatin analogue inhibitors of growth hormone
US8137512B2 (en) * 2006-09-04 2012-03-20 National Institute Of Advanced Industrial Science And Technology Process for analyzing sample by capillary electrophoresis method
EP2060912B1 (en) * 2006-09-04 2014-10-01 National Institute of Advanced Industrial Science and Technology Method for analysis of sample by capillary electrophoresis
US20100155242A1 (en) * 2006-09-04 2010-06-24 Arkray, Inc. Method of Analyzing a Sample by Capillary Electrophoresis
JP2009186445A (ja) * 2008-02-08 2009-08-20 Arkray Inc キャピラリー電気泳動法によるヘモグロビンの分析方法およびそれに用いる試薬
AU2010217297A1 (en) 2009-02-25 2011-10-20 Supratek Pharma, Inc. Bendamustine cyclopolysaccharide compositions
US8389558B2 (en) * 2009-07-20 2013-03-05 Supratek Pharma Inc. Bendamustine amphiphilic anionic compositions
US20110015245A1 (en) * 2009-07-20 2011-01-20 Valery Alakhov Bendamustine amphiphilic cationic compositions
AU2011228758A1 (en) 2010-03-13 2012-11-08 Eastpond Laboratories Limited Fat-binding compositions
US8383663B2 (en) 2010-07-19 2013-02-26 Supratek Pharma Inc. Bendamustine anionic-catioinic cyclopolysaccharide compositions
US20120171184A1 (en) 2010-12-31 2012-07-05 Lajos Szente Cellular hydration compositions
EP2658578A1 (en) 2010-12-31 2013-11-06 Eastpond Laboratories Limited Cellular hydration compositions containing cyclodextrins
BR112013018933A2 (pt) * 2011-02-10 2016-09-13 Unilever Nv composições antiviral, antisséptica líquida, e sólida para a lavagem pessoal, de limpeza sólida e líquida da superfície rígida, antimicrobiana, higienizadora de mãos, método de desinfecção de uma superfície e utilização de uma composição
CA2861314C (en) 2012-01-18 2021-03-16 Surmodics, Inc. Lubricious medical device coating with low particulates
US11439594B2 (en) * 2012-12-04 2022-09-13 Phosphorex, Inc. Microparticles and nanoparticles having negative surface charges
AU2014265275B2 (en) * 2013-05-17 2019-10-03 Marquette University Composite materials containing structural polysaccharides and macrocyclic compounds formed from ionic liquid compositions
JP5673756B2 (ja) * 2013-08-20 2015-02-18 東洋紡株式会社 医療用材料
RU2597085C2 (ru) * 2013-11-07 2016-09-10 Федеральное государственное бюджетное учреждение науки Институт биологии моря им. А.В. Жирмунского Дальневосточного отделения Российской академии наук (ИБМ ДВО РАН) Имплантируемый матриксный материал для регенеративной медицины и способ его получения (варианты)
WO2016206738A1 (en) 2015-06-24 2016-12-29 Kao Germany Gmbh Hair treatment process
US10342898B2 (en) * 2015-12-29 2019-07-09 Surmodics, Inc. Lubricious coatings with surface salt groups
US11174447B2 (en) 2015-12-29 2021-11-16 Surmodics, Inc. Lubricious coatings with surface salt groups
DK3528856T3 (da) 2016-10-18 2023-10-16 Univ Marquette Kompositmaterialer, der indeholder strukturelle polymerer og fotoreaktive nitrogenoxidfrigørende midler og anvendelser deraf til sårbandager
WO2020257316A1 (en) 2019-06-17 2020-12-24 Marquette University Materials based on natural pollen grains and uses thereof
WO2021205237A1 (en) 2020-04-06 2021-10-14 Eastpond Laboratories Limited Compositions for promoting cellular hydration
CN114344557A (zh) * 2022-01-10 2022-04-15 山东万容生物科技有限公司 一种含环糊精的水胶体敷料及其制备方法
US20250270757A1 (en) * 2022-04-29 2025-08-28 Drexel University Surfactant-loaded mof-based antiviral fabric for use in facemasks and respirators

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE670837A (es) * 1964-10-14 1966-01-31
JPS61251616A (ja) * 1985-04-30 1986-11-08 Agency Of Ind Science & Technol 溶質の放出量の制御方法
JPS6416728A (en) * 1987-07-07 1989-01-20 Santen Pharmaceutical Co Ltd Aqueous preparation
JPH03234770A (ja) * 1990-02-09 1991-10-18 Nippon Shokubai Kagaku Kogyo Co Ltd 電気刺激応答性ゲルの製法
US5324718A (en) * 1992-07-14 1994-06-28 Thorsteinn Loftsson Cyclodextrin/drug complexation
US5464650A (en) * 1993-04-26 1995-11-07 Medtronic, Inc. Intravascular stent and method
SE9303627D0 (sv) * 1993-11-03 1993-11-03 Kabi Pharmacia Ab Method and means for prevention of cataract
JPH08134134A (ja) * 1994-11-09 1996-05-28 Nippon Shokubai Co Ltd 粒子状含水ゲル重合体の乾燥方法
JP3297969B2 (ja) * 1994-12-26 2002-07-02 ライオン株式会社 点眼剤
TW434023B (en) * 1995-09-18 2001-05-16 Novartis Ag Preserved ophthalmic composition
JPH0995413A (ja) * 1995-09-29 1997-04-08 Shiseido Co Ltd 皮膚外用剤
RU2173172C2 (ru) * 1997-05-05 2001-09-10 Сайдекс Инк. Твердые фармацевтические препараты, содержащие физическую смесь сульфоалкилового эфира циклодекстрина и терапевтического агента
GB9718568D0 (en) * 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
WO2000004916A1 (en) * 1998-07-23 2000-02-03 Societe De Conseils De Recherches Et D'applications Scientifiques Sas Encapsulation of water soluble peptides
US6482942B1 (en) * 1999-01-12 2002-11-19 Biotechnology Services And Consulting, Inc. Method of isolating mucilaginous polysaccharides and uses thereof
JP2001318350A (ja) * 2000-05-11 2001-11-16 Lion Corp コンタクトレンズ用溶液
ES2292586T3 (es) * 2000-05-15 2008-03-16 THE PROCTER & GAMBLE COMPANY Composiciones que comprenden ciclodextrina.
US20020147232A1 (en) * 2000-05-26 2002-10-10 Claus Sundgreen Pharmaceutical compositions comprising desglymidodrine as an active drug substance
PE20020146A1 (es) * 2000-07-13 2002-03-31 Upjohn Co Formulacion oftalmica que comprende un inhibidor de ciclooxigenasa-2 (cox-2)
AU2002213429A1 (en) * 2000-09-28 2002-04-08 Immugen Pharmaceuticals, Inc. Antiviral methods and compounds

Also Published As

Publication number Publication date
CN1646171A (zh) 2005-07-27
ES2392964T3 (es) 2012-12-17
RU2004133887A (ru) 2005-10-20
PT1499361E (pt) 2012-11-22
KR20040103968A (ko) 2004-12-09
NZ535810A (en) 2007-11-30
ZA200407794B (en) 2006-02-22
RU2321597C2 (ru) 2008-04-10
NO20044979L (no) 2004-11-16
WO2003089008A1 (en) 2003-10-30
PL371595A1 (en) 2005-06-27
PL215579B1 (pl) 2013-12-31
EP1499361A1 (en) 2005-01-26
JP2005529879A (ja) 2005-10-06
AU2003224099A1 (en) 2003-11-03
US20080299166A1 (en) 2008-12-04
BR0309340A (pt) 2005-03-08
US20050163853A1 (en) 2005-07-28
AU2003224099B2 (en) 2006-11-09
IL164627A0 (en) 2005-12-18
EP1499361B1 (en) 2012-08-08
JP4648632B2 (ja) 2011-03-09
KR101121675B1 (ko) 2012-03-13
IL164627A (en) 2009-11-18
MXPA04010325A (es) 2005-06-08
CN1646171B (zh) 2010-05-26
CA2484100C (en) 2012-01-03
CA2484100A1 (en) 2003-10-30
US20120040901A1 (en) 2012-02-16
HK1073070A1 (en) 2005-09-23

Similar Documents

Publication Publication Date Title
CO5611168A2 (es) Biomateriales novedosos, su preparacion y su uso
ES2185429T3 (es) Composiciones de campu acondicionador.
BR0312679A (pt) Composição de máscara contendo composição lìquida emulsificada
BRPI0519188A2 (pt) composiÇço detergente lÍquida substancialmente nço-aquosa, envelope de polÍmero solével em Água, e, uso de composiÇço ou de envelope
AR053054A1 (es) Composiciones detergentes liquidas para lavanderia que tienen mayor estabilidad y transparencia
CO4440536A1 (es) Metodo para la preparacion de una dispersion acuosa de poli- mero
AR023304A1 (es) Composiciones champu
AR016781A1 (es) Composicion detergente acuosa en gel de lavar ropa.
AR092774A1 (es) Composicion de limpieza que comprende variantes de amilasa con alta estabilidad en la presencia de un agente quelante
BRPI0703508A (pt) copolìmero em emulsão aquosa, anfifìlico, e, método para produzir copolìmero em emulsão, anfifìlico
AR030043A1 (es) Sistema de agentes de hidrofobizado, polisiloxano, procedimiento para la obtencion de polisiloxanos, dispersiones acuosas, procedimiento para la obtencion de dispersiones acuosas, procedimiento para el hidrofobizado de sustratos, sustratos hidrofobizados y empleo del sistema de agentes de hidrofobiz
BRPI0520279A2 (pt) sistemas e mÉtodos para turbinas a vento acorrentadas
FR2914647B1 (fr) Copolymere comprenant des unites betainiques et des unites hydrophobes et/ou amphiphiles,procede de preparation,et utilisations.
ATE468378T1 (de) Tensidmischungen für die tertiäre erdölförderung
BR0016796A (pt) Composições antimicrobianas e métodos de uso
BRPI0518701B8 (pt) Processos para a preparação de um sistema catalisador e para a polimerização de olefinas
EP1786893A4 (en) STRUCTURED VISCOSE TENSID COMPOSITIONS OF LOW PH
BR0210828A (pt) Preparações de agentes corantes à base de água para a impressão inkjet
AR032869A1 (es) Composiciones liquidas de limpieza y su uso
DE602004014751D1 (de) Reinigungsmittel vom typ der multiplen emulsion
PT1129052E (pt) Composicoes que compreendem agentes anti-chuvisco e processos e metodos para o seu uso
MX9401211A (es) Composicion y procedimiento para combatir la aglomeracion de abonos.
GT201000138A (es) " mezcla herbicida "
AR004057A1 (es) Mejoras en composiciones organicas o referidas a ellas.
BR0109121A (pt) Processo para a aglomeração de látex de polibutadieno finamente divididos

Legal Events

Date Code Title Description
FG Application granted